PerpEquities

Kodiak Sciences Inc. (KOD) balance sheet

NASDAQ · Healthcare · Biotechnology · 141 employees · CEO Victor Perlroth

Price
$99.18 -1.22%
Market cap
$6.23B
Enterprise value
$6.2B
Last report
Q2 '26 filed 2026-08-13
Next report
2026-11-12 EPS est. -$1.06

At the end of Q2 '26 Kodiak Sciences Inc. (KOD) held $126M in cash and short-term investments against $95.7M of debt incl. leases. Total assets $257M, total liabilities $196M, shareholders' equity $61.1M.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents$346M$286M$246M$219M$198M$168M$139M$104M$72M$210M$170M$126M
Other current assets$5.26M$3.8M$5.59M$5.4M$4.63M$3.86M$3.83M$3.75M$3.69M$4.95M$5.73M$5.46M
Current assets$351M$289M$252M$225M$202M$172M$143M$108M$75.7M$215M$175M$131M
Property, plant & equipment (net)$182M$175M$168M$162M$155M$149M$140M$134M$127M$122M$116M$111M
Long-term investments$6.32M$6.32M$6.18M$6.18M$6.18M$6.18M$6.18M$6.18M$6.18M$6.18M$6.18M$6.18M
Other non-current assets$8.73M$8.72M$8.7M$8.86M$8.74M$8.73M$8.66M$8.66M$8.68M$8.67M$8.68M$8.66M
Non-current assets$197M$190M$183M$177M$170M$164M$155M$149M$142M$137M$131M$125M
Total assets$548M$479M$435M$402M$373M$336M$298M$257M$218M$352M$306M$257M
Liabilities
Accounts payable$38.6M$13.6M$2.49M$1.87M$3.29M$3.92M$6.54M$5.06M$10.4M$12.9M$11.3M$12.6M
Accrued expenses$5.41M$6.08M$5.68M$3.94M$10.6M$11M$13.4M$14.7M$20.3M$7.77M$8.48M$0
Short-term debt$9.02M$9.77M$9.61M$0$0$0$0$0$0$12.1M$11.7M$9.81M
Other current liabilities$17.8M$12.3M$7.08M$5.51M$0$0$0$0$0$12.8M$18.1M$30.3M
Current liabilities$70.8M$41.7M$24.9M$21.2M$24.1M$25.6M$30.9M$31M$42.4M$45.5M$49.6M$52.8M
Long-term debt$100M$100M$100M$0$0$0$0$0$0$100M$100M$42.9M
Lease obligations (non-current)$74.5M$71.9M$68.7M$65.9M$63.2M$59.7M$56.7M$53.9M$50.4M$47.1M$44.3M$42.9M
Other non-current liabilities$0$0$0$100M$100M$100M$102M$102M$102M$1.5M$0$57.1M
Non-current liabilities$174M$172M$169M$166M$163M$160M$158M$155M$152M$149M$144M$143M
Total liabilities$245M$214M$194M$187M$187M$185M$189M$186M$194M$194M$194M$196M
Equity
Common stock & paid-in capital$5K$5K$5K$5K$5K$5K$5K$5K$5K$6K$6K$6K
Retained earnings-$1.09B-$1.15B-$1.2B-$1.24B-$1.28B-$1.33B-$1.39B-$1.44B-$1.5B-$1.56B-$1.62B-$1.68B
Shareholders' equity$302M$266M$241M$215M$185M$150M$109M$70.3M$23.7M$157M$112M$61.1M
Debt
Total debt (incl. leases)$183M$182M$178M$75.8M$73.4M$70.3M$67.6M$65.2M$62.2M$159M$156M$95.7M
Net debt (debt - cash)-$162M-$104M-$67.6M-$143M-$124M-$97.7M-$71.2M-$39M-$9.84M-$50.7M-$13.5M-$30.2M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

Data as of 2026-11-02